Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels

This publication has 14 references indexed in Scilit:

• Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C
  Gastroenterology, 2002
• Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis
  Clinical Therapeutics, 2002
• Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels
  International Journal of Pharmaceutics, 2001
• Isoniazid pharmacokinetics in children according to acetylator phenotype
  Fundamental & Clinical Pharmacology, 2001
• Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized Trial
  JAMA, 2000
• Resistance, Fitness, Adherence, and Potency
  Published by American Medical Association (AMA) ,2000
• Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy
  JAMA, 2000
• A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence
  Journal of Paediatrics and Child Health, 1999
• Directly Observed Therapy for Treatment Completion of Pulmonary TuberculosisConsensus Statement of the Public Health Tuberculosis Guidelines Panel
  JAMA, 1998
• Strategies to improve compliance with therapy
  The American Journal of Medicine, 1985